Selenium, folate, and colon cancer

Nutrition and Cancer

Volumn 61, Issue 2, 2009, Pages 165-178

  Connelly Frost, Alexandra ^a,b   Poole, Charles ^a   Satia, Jessie A ^a   Kupper, Lawrence L ^a   Millikan, Robert C ^a   Sandler, Robert S ^a  

^a IL   (United States)

^b Frost Consulting Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; SELENIUM;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; COLON CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET; FEMALE; HUMAN; INTERVIEW; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; WEIGHT REDUCTION;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; BIAS (EPIDEMIOLOGY); CASE-CONTROL STUDIES; COLONIC NEOPLASMS; DIET; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLIC ACID; HUMANS; LIFE STYLE; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM STAGING; NORTH CAROLINA; ODDS RATIO; SELENIUM; WEIGHT LOSS;

EID: 61649095217     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635580802404188     Document Type: Article

References (62)

1. Parkin DM: International variation. Oncogene 23, 6329-6340, 2004.
2. Jansson B: Geographic mappings of colorectal cancer rates: a retrospect of studies, 1974-1984. Cancer Detect Prev 8, 341-348, 1985.
3. Boyle P and Zaridze DG: Colorectal cancer as a disease of the environment. Ecol Dis 2, 241-248, 1983.
4. Miller AB: Risk factors from geographic epidemiology for gastrointestinal cancer. Cancer 50, 2533-2540, 1982.
5. Groff J and Gropper S: Microminerals. Advanced Nutrition and Human Metabolism. Belmont, CA: Wadsworth, 1999, pp. 401-470.
6. Food and Nutrition Board of the Institute of Medicine. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids: A Report of the Panel on Dietary Antioxidants and Related Compounds, Subcommittees on Upper Reference Levels of Nutrients and the Interpretation and Use of Dietary Reference Intakes, and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Washington, DC: National Academy Press, 2000.
7. Niskar AS, Paschal DC, Kieszak SM, Flegal KM, Bowman B, et al.: Serum selenium levels in the US population: third National Health and Nutrition Examination Survey, 1988-1994. Biol Trace Elem Res 91, 1-10, 2003.
8. Moriarty PM, Picciano MF, Beard JL, and Reddy CC: Classical selenium-dependent glutathione peroxidase expression is decreased secondary to iron deficiency in rats. J Nutr 125, 293-301, 1995.
9. Olin KL, Walter RM, and Keen CL: Copper deficiency affects selenoglutathione peroxidase and selenodeiodinase activities and antioxidant defense in weanling rats. Am J Clin Nutr 59, 654-658, 1994.
10. Forbes RM and Erdman JW Jr.: Bioavailability of trace mineral elements. Annu Rev Nutr 3, 213-221, 1983.
11. Davis CD and Uthus EO: DNA methylation, cancer susceptibility, and nutrient interactions. Exp Biol Med (Maywood) 229, 988-995, 2004.
12. Davis CD and Uthus EO: Dietary folate and selenium affect dimethylhydrazine-induced aberrant crypt formation, global DNA methylation and one-carbon metabolism in rats. J Nutr 133, 2907-2914, 2003.
13. Combs GF Jr. and Gray WP: Chemopreventive agents: selenium. Pharmacol Ther 79, 179-192, 1998.
14. Ganther HE: Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase. Carcinogenesis 20, 1657-1666, 1999.
15. Ip C: Lessons from basic research in selenium and cancer prevention. J Nutr 128, 1845-1854, 1998.
16. Longtin R: Selenium for prevention: eating your way to better DNA repair? J Natl Cancer Inst 95, 98-100, 2003.
17. Clark LC, Combs GF Jr, Turnbull BW, Slate EH, Chalker DK, et al.: Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: a randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 276, 1957-1963, 1996.
18. Duffield-Lillico AJ, Reid ME, Turnbull BW, Combs GF, Slate EH, et al.: Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention Cancer Trial. Cancer Epidemiol Biomarkers Prev 11, 630-639, 2002.
19. Diplock AT: Indexes of selenium status in human populations. Am J Clin Nutr 57, 256S-258S, 1993.
20. Fan AM and Kizer KW: Selenium: nutritional, toxicologic, and clinical aspects. West J Med 153, 160-167, 1990.
21. Mason AC: Selenium. In: Trace Minerals in Foods, Smith KT (ed.). New York: Marcel Dekker, Inc., 1988, pp. 325-355.
22. Fernandez-Banares F, Cabre E, Esteve M, Mingorance MD, Abad-Lacruz A, et al.: Serum selenium and risk of large size colorectal adenomas in a geographical area with a low selenium status. Am J Gastroenterol 97, 2103-2108, 2002.
23. Schober SE, Comstock GW, Helsing KJ, Salkeld RM, Morris JS, et al.: Serologic precursors of cancer: I. prediagnostic serum nutrients and colon cancer risk. Am J Epidemiol 126, 1033-1041, 1987.
24. Ghadirian P, Maisonneuve P, Perret C, Kennedy G, Boyle P, et al.: A case-control study of toenail selenium and cancer of the breast, colon, and prostate. Cancer Detect Prev 24, 305-313, 2000.
25. Mikac-Devic M, Vukelic N, and Kljaic K: Serum selenium level in patients with colorectal cancer. Biol Trace Elem Res 33, 87-94, 1992.
26. Salonen JT, Alfthan G, Huttunen JK, and Puska P: Association between serum selenium and the risk of cancer. Am J Epidemiol 120, 342-349, 1984.
27. Willett WC, Polk BF, Morris JS, Stampfer MJ, Pressel S, et al.: Prediagnostic serum selenium and risk of cancer. Lancet 2, 130-134, 1983.
28. Nomura A, Heilbrun LK, Morris JS, and Stemmermann GN: Serum selenium and the risk of cancer, by specific sites: case-control analysis of prospective data. J Natl Cancer Inst 79, 103-108, 1987.
29. Knekt P, Aromaa A, Maatela J, Alfthan G, Aaran RK, et al.: Serum vitamin E, serum selenium and the risk of gastrointestinal cancer. Int J Cancer 42, 846-850, 1988.
30. Nelson RL, Davis FG, Sutter E, Kikendall JW, Sobin LH, et al.: Serum selenium and colonic neoplastic risk. Dis Colon Rectum 38, 1306-1310, 1995.
31. Garland M, Morris JS, Stampfer MJ, Colditz GA, Spate VL, et al.: Prospective study of toenail selenium levels and cancer among women. J Natl Cancer Inst 87, 497-505, 1995.
32. Poole C: High Dietary Selenium Intake and Incidence of Cancers of the Lung, Breast and Large Bowel [dissertation]. Cambridge, MA: Harvard School of Public Health, 1989.
33. van den Brandt PA, Goldbohm RA, van V, Bode P, Dorant E, et al.: A prospective cohort study on toenail selenium levels and risk of gastrointestinal cancer. J Natl Cancer Inst 85, 224-229, 1993.
34. Hawker FH, Stewart PM, and Snitch PJ: Effects of acute illness on selenium homeostasis. Crit Care Med 18, 442-446, 1990.
35. Dworkin BM, Rosenthal WS, Mittelman A, Weiss L, Applebee-Brady L, et al.: Selenium status and the polyp-cancer sequence: a colonoscopically controlled study. Am J Gastroenterol 83, 748-751, 1988.
36. Westin T, Ahlbom E, Johansson E, Sandstrom B, Karlberg I, et al.: Circulating levels of selenium and zinc in relation to nutritional status in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 115, 1079-1082, 1989.
37. American Gastroenterological Association. Colorectal Cancer Detection and Prevention. Bethesda, MD: American Gastroenterological Association, 2003.
38. Potter JD and Hunter D: Colorectal Cancer. In: Textbook of Cancer Epidemiology, Adami HO, Hunter DJ, and D Trichopoulos (eds.). New York: Oxford University Press, 2002, pp. 188-211.
39. Butler LM, Sinha R, Millikan RC, Martin CF, Newman B, et al.: Heterocyclic amines, meat intake, and association with colon cancer in a population-based study. Am J Epidemiol 157, 434-445, 2003.
40. Satia-Abouta J, Galanko JA, Potter JD, Ammerman A, Martin CF, et al.: Associations of total energy and macronutrients with colon cancer risk in African Americans and Whites: results from the North Carolina colon cancer study. Am J Epidemiol 158, 951-962, 2003.
41. Satia-Abouta J, Galanko JA, Martin CF, Potter JD, Ammerman A, et al.: Associations of micronutrients with colon cancer risk in African Americans and whites: results from the North Carolina Colon Cancer Study. Cancer Epidemiol Biomarkers Prev 12, 747-754, 2003.
42. Aldrich TE, Vann D, Moorman PG, and Newman B: Rapid reporting of cancer incidence in a population-based study of breast cancer: one constructive use of a central cancer registry. Breast Cancer Res Treat 35, 61-64, 1995.
43. Weinberg CR and Wacholder S: The design and analysis of case-control studies with biased sampling. Biometrics 46, 963-975, 1990.
44. Block G, Hartman AM, Dresser CM, Carroll MD, Gannon J, et al.: A databased approach to diet questionnaire design and testing. Am J Epidemiol 124, 453-469, 1986.
45. Gerber AM, James SA, Ammerman AS, Keenan NL, Garrett JM, et al.: Socioeconomic status and electrolyte intake in black adults: the Pitt County Study. Am J Public Health 81, 1608-1612, 1991.
46. Jacobson BE and Lockitch G: Direct determination of selenium in serum by graphite-furnace atomic absorption spectrometry with deuterium background correction and a reduced palladium modifier: age-specific reference ranges. Clin Chem 34, 709-714, 1988.
47. Blair SN, Haskell WL, Ho P, Paffenbarger RS Jr, Vranizan KM, et al.: Assessment of habitual physical activity by a seven-day recall in a community survey and controlled experiments. Am J Epidemiol 122, 794-804, 1985.
48. Kok FJ, de Bruijn AM, Hofman A, Vermeeren R, and Valkenburg HA: Is serum selenium a risk factor for cancer in men only? Am J Epidemiol 125, 12-16, 1987.
49. Hosmer DW and Lemeshow S: Confidence interval estimation of interaction. Epidemiology 3, 452-456, 1992.
50. Weinberg CR and Sandler DP: Randomized recruitment in case-control studies. Am J Epidemiol 134, 421-432, 1991.
51. van den Brandt PA, Goldbohm RA, van't Veer P, Bode P, Hermus, RJ, et al.: Predictors of toenail selenium levels in men and women. Cancer Epidemiol Biomarkers Prev 2, 107-112, 1993.
52. Giovannucci E: Epidemiologic studies of folate and colorectal neoplasia: a review. J Nutr 132, 2350S-2355S, 2002.
53. Kim YI: Nutritional epigenetics: impact of folate deficiency on DNA methylation and colon cancer susceptibility. J Nutr 135, 2703-2709, 2005.
54. Kim YI: Role of folate in colon cancer development and progression. J Nutr 133, 3731S-3739S, 2003.
55. Lamprecht SA and Lipkin M: Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms. Nat Rev Cancer 3, 601-614, 2003.
56. Kim YI: Folic acid fortification and supplementation-good for some but not so good for others. Nutr Rev 65, 504-511, 2007.
57. Kim YI: Will mandatory folic acid fortification prevent or promote cancer? Am J Clin Nutr 80, 1123-1128, 2004.
58. Mason JB, Dickstein A, Jacques PF, Haggarty P, Selhub J, et al.: A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiol Biomarkers Prev 16, 1325-1329, 2007.
59. Kim YS and Milner J: Molecular targets for selenium in cancer prevention. Nutr Cancer 40, 50-54, 2001.
60. Wintergerst ES, Maggini S, and Hornig DH: Contribution of selected vitamins and trace elements to immune function. Ann Nutr Metab 51, 301-323, 2007.
61. Ferguson LR, Karunasinghe N, and Philpott M: Epigenetic events and protection from colon cancer in New Zealand. Environ Mol Mutagen 44, 36-43, 2004.
62. Satia JA, King IB, Morris JS, Stratton K, and White E: Toenail and plasma levels as biomarkers of selenium exposure. Ann Epidemiol 16, 53-58, 2006.